Sotac Pharmaceuticals IPO Particulars & Guidance at Chanakyanipothi.com, the Oldest & the most Trusted Investment website in India for coming up IPOs. Operational since 8th December 1999, this is the Only Investment Platform in India, which has successfully completed 23 Years.

    Sotac Pharmaceuticals IPO particulars & guidance

    Sotac Pharmaceuticals IPO Listing:
    The scrip received marginal positive listing as mentioned by us in our guidance. Compared to issue price of Rs.111, the scrip listed at Rs. 115.

    Sotac Pharmaceuticals IPO Guidance:
    Gujarat based company has shown steady rise in its turnover and bottomline. The IPO size is large and due to weak market mood, bumper oversubscription is not expected. There is not much fancy seen in the grey market. Marginal positive listing is expected.

     

    Sotac Pharmaceuticals IPO Grey Market updates 
    Prior to listing
    GMP:  Rs.10/11 few trades seen
    Subject to:  No Trades

    Sotac Pharmaceuticals IPO Subscription Status
    On 3 April 2023 @ 3.00 (Closed)
    QIB(net) 570000  Shares, 1.00T
    NII:        428400   Shares, 4.04T
    RII:         998400   Shares,0.91T
    Total:     2850000 Shares  1.60T

    Sotac Pharmaceuticals IPO Particulars & Guidance: About the business

    SOTAC Group is pharma manufacturer, specializing in manufacturing of a wide range of pharmaceutical products such as Non Beta-Lactam (general) tablets, Non Beta-Lactam (general) capsules, Non Beta-lactam Syrup and external preparations through issuer company SOTAC Pharmaceuticals Limited. Beta-lactam coated tablets, beta-lactam uncoated tablets, betalactam capsules, oral liquid, dry syrup and external preparations such as nasal spray, relief spray and cream through 71% subsidiary company through SOTAC Healthcare Private Limited. It will be commencing manufacturing of Nutraceuticals
    products and food products through newly incorporated 51% subsidiary SOTAC Lifescience Private Limited. The company is committed to provide a wide range of quality and affordable pharmaceutical products to a large number of healthcare professionals.
    The group’s therapeutic portfolio includes Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Iron, Anti-Cold, AntiAllergic, Derma Products, Antacid, Anti-Ulcerants, PPI, Anti-Emetics, Cardiac, Anti-Hypertensives, Analgesic, Anti Pyretic, Anti-Inflammatory, Anti-Bacterial, Anti-Viral, General Antibiotics IP-Lactams & Non-IP-Lactams, Anti-Fungal, Cephalosporin.

    The group’s past and present clientele includes renowned pharma marketers and manufactures namely Cadila Pharma, J. B. Chemical, Lincoln Pharma, Intas Pharma, Viatris (Mylan), Makers (Ipca), Corona Remedies, Eris Lifesciences, Stride Pharma, Stalion Pharma, Acme Pharma, Olecare Pharma, Treatwell Pharma, Ronak Healthcare, Curever Pharma, Kentoss Pharma, Sunrest Pharma, Ishan Healthcare etc.

    The pharmaceutical manufacturing facilities are situated at Sanand GIDC–II in Ahmedabad district of Gujarat, which offers easy and convenient accessibility. Its infrastructure consists of comprehensive production unit, quality control department quality assurance microbiological laboratory, raw material and finished product storage. The group’s manufacturing facilities are WHO-GMP accredited. In past, the manufacturing facility was also accredited with Kenya PPB and Ivory coast. SOTAC Pharmaceuticals Limited is also registered in USA with DUNS number.

    For more information about the company, Click www.sotacpharma.com

    Sotac Pharmaceuticals IPO Details
    IPO opens on   29 March 2023
    IPO closes on   03 April   2023
    Issue Type Book Built Issue IPO
    Issue Size 3000000 Sh /Rs 33.30 Cr
    * Fresh Issue 3000000 Sh /Rs 33.30 Cr
    * Offer for Sale  – Sh /Rs – Cr
       
    Face Value per share: Rs. 10
       
    Price Band Rs.105-111
    Employee discount  Rs. 0 per share
    Retail Lot Size  1200 Shares
    Listing will at  NSE Sme
    Shares offered to
      Shares Rs. (Cr)
    QII (50 %)  1425000 15.82
    NII (15 %)  427500 4.75
    RII (35 %) 997500 11.07
    Total Shares  2850000 31.64
    Retail portion will be oversubscribed by  831
    Forms
    How much Shares to Apply?
    Min Retail Application 1200 Sh Rs. 133200
    Min HNI Application  2400 Sh Rs. 266400

    Promoters of the IPO
    Mr. Sharadkumar D. Patel, Mr. Dineshkumar B. Gelot, Mr. Vishalkumar D. Patel, Mr. Chetankumar B. Patel & Mrs. Kiran Baldevbhai Jotania

    Objects of the IPO:
    The Company proposes to utilize the Net Proceeds from the Issue towards
    1. To Meet Working Capital Requirements
    2. Investment in Subsidiary
    3. Upgradation / Construction of Existing /New Building in the Existing Premises

    IPO Tentative timetable
    IPO opens on 29   March 2023
    IPO Closes on 03   April 2023
    IPO Allotment on  10   April 2023
    Unblocking of ASBA  11   April 2023
    Credit of Shares 12   April 2023
    Listing on 13   April 2023
    Registered Office of the Company
    Plot No. PF-21, Nr. ACME Pharma, Opp. Teva Pharma Sanand GIDC-II, Sanand Ahmedabad -382110, Gujarat, India
    IPO Lead Managers 
    Beeline Capital Advisors Private Limited
    Registrar to the IPO
    KFin Technologies Limited
    IPO Financial & Analytical Ratios
    Year Total Income Net Profit EPS RoNW
      Rs.in Cr Rs.in Cr Rs. %
    2019-20 28.76 0.71 1.05 20.93
    2020-21 43.52 0.86 1.07 20.43
    2021-22  73.37 2.88 3.58 43.47
    Book Value of the Share on 31.03.2022 Rs.8.23    
    Book Value of the Share after the IPO Rs.-    
    Offer Price   Rs. 111    
    Ratio Analysis
    Upper Price/last EPS 31.01
    Upper price/BV Ratio
    Upper price/BV after IPO  13.48

    Sotac Pharmaceuticals IPO Particulars & Guidance
    Peer Comparison: 

    As on date of DRHP FV Income  PE
      Rs.  in Cr Ratio of
    The IPO Company 10 73.15 31.01
    Lincoln Pharmaceuticals 10 472.08 9.14
           
           
           
           
           

     

    # This is only coverage of News related to Grey Market. We do not deal in grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.

    >>Go to Mainboard IPOs Section: Click
    >>Get Good Staff or Job, Click: Staffavailable.com
    >>Interested in Used Automobiles or vintage cars? Click: BigGaddi.com
    >>Get solid Guidance on Mutual fund Investments, Click: ChanakyaMFGuidance.com
    >>Study Stock Research Reports, Click: AnalysisLibrary.com
    >>
    Interested in Crossword Puzzles? Click: Magajmari.com

    Leave a Reply

    Your email address will not be published. Required fields are marked *